BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

22 related articles for article (PubMed ID: 29453135)

  • 1. Design, synthesis and structure–activity relationship studies of morpholino-1H-phenalene derivatives that antagonize Mcl-1/Bcl-2.
    Li X; Liang X; Song T; Su P; Zhang Z
    Bioorg Med Chem; 2014 Nov; 22(21):5738-46. PubMed ID: 25584387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small molecules targeting protein-protein interactions for cancer therapy.
    Wu D; Li Y; Zheng L; Xiao H; Ouyang L; Wang G; Sun Q
    Acta Pharm Sin B; 2023 Oct; 13(10):4060-4088. PubMed ID: 37799384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imidazoles as Serotonin Receptor Modulators for Treatment of Depression: Structural Insights and Structure-Activity Relationship Studies.
    Goel KK; Thapliyal S; Kharb R; Joshi G; Negi A; Kumar B
    Pharmaceutics; 2023 Aug; 15(9):. PubMed ID: 37765177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of bicyclic compounds that act as dual inhibitors of Bcl-2 and Mcl-1.
    Uthale A; Anantram A; Sulkshane P; Degani M; Teni T
    Mol Divers; 2023 Jun; 27(3):1359-1374. PubMed ID: 35909144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular mechanism underlying the apoptotic modulation by ethanol extract of Pseudolarix kaempferi in mucoepidermoid carcinoma of the salivary glands.
    Choi SJ; Ahn CH; Hong KO; Kim JH; Hong SD; Shin JA; Cho SD
    Cancer Cell Int; 2021 Aug; 21(1):427. PubMed ID: 34391437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting MCL-1 in cancer: current status and perspectives.
    Wang H; Guo M; Wei H; Chen Y
    J Hematol Oncol; 2021 Apr; 14(1):67. PubMed ID: 33883020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of Anti-Apoptotic Bcl-2 Proteins in Preclinical and Clinical Studies: Current Overview in Cancer.
    D'Aguanno S; Del Bufalo D
    Cells; 2020 May; 9(5):. PubMed ID: 32455818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1,2,3-Triazole-containing hybrids as leads in medicinal chemistry: A recent overview.
    Bozorov K; Zhao J; Aisa HA
    Bioorg Med Chem; 2019 Aug; 27(16):3511-3531. PubMed ID: 31300317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of potent Mcl-1/Bcl-xL dual inhibitors by using a hybridization strategy based on structural analysis of target proteins.
    Tanaka Y; Aikawa K; Nishida G; Homma M; Sogabe S; Igaki S; Hayano Y; Sameshima T; Miyahisa I; Kawamoto T; Tawada M; Imai Y; Inazuka M; Cho N; Imaeda Y; Ishikawa T
    J Med Chem; 2013 Dec; 56(23):9635-45. PubMed ID: 24215352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual inhibitors of the pro-survival proteins Bcl-2 and Mcl-1 derived from natural compound meiogynin A.
    Abou Samra A; Robert A; Gov C; Favre L; Eloy L; Jacquet E; Bignon J; Wiels J; Desrat S; Roussi F
    Eur J Med Chem; 2018 Mar; 148():26-38. PubMed ID: 29453135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pro-apoptotic meiogynin A derivatives that target Bcl-xL and Mcl-1.
    Desrat S; Pujals A; Colas C; Dardenne J; Gény C; Favre L; Dumontet V; Iorga BI; Litaudon M; Raphaël M; Wiels J; Roussi F
    Bioorg Med Chem Lett; 2014 Nov; 24(21):5086-8. PubMed ID: 25266781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of an efficient route toward meiogynin A-inspired dual inhibitors of Bcl-xL and Mcl-1 anti-apoptotic proteins.
    Desrat S; Remeur C; Roussi F
    Org Biomol Chem; 2015 May; 13(19):5520-31. PubMed ID: 25877523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. From meiogynin A to the synthesis of dual inhibitors of Bcl-xL and Mcl-1 anti-apoptotic proteins.
    Desrat S; Remeur C; Gény C; Rivière G; Colas C; Dumontet V; Birlirakis N; Iorga BI; Roussi F
    Chem Commun (Camb); 2014 Aug; 50(62):8593-6. PubMed ID: 24956071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 1-Phenyl-1H-indole derivatives as a new class of Bcl-2/Mcl-1 dual inhibitors: Design, synthesis, and preliminary biological evaluation.
    Xu G; Liu T; Zhou Y; Yang X; Fang H
    Bioorg Med Chem; 2017 Oct; 25(20):5548-5556. PubMed ID: 28866374
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.